Monofunctional chemotherapeutic alkylating drugs produce 3-methyladenine in dsDNA

Stable Identifier
R-HSA-9730736
Type
Reaction [omitted]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Alkylating chemotherapeutic drugs from the triazene group, dacarbazine (Braybrook et al. 2000), temozolomide (Deans and Tisdale 1992), and streptozocin (streptozotocin) (Bennett and Pegg 1981 - study was performed in rats), and probably procarbazine, produce 3-metyladenine adducts on DNA (3meA-dsDNA) (reviewed by Fu et al. 2012).

Literature References
PubMed ID Title Journal Year
10663625 Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen

Braybrooke, JP, Houlbrook, S, Crawley, JE, Propper, DJ, O'Byrne, KJ, Stratford, IJ, Harris, AL, Shuker, DE, Talbot, DC

Cancer Chemother Pharmacol 2000
1562991 Antitumour imidazotetrazines XXVIII 3-methyladenine DNA glycosylase activity in cell lines sensitive and resistant to temozolomide

Deans, B, Tisdale, MJ

Cancer Lett 1992
Participants
Participates
Inferred From
Authored
Reviewed
Created
Cite Us!